CSIMarket
 
Bio techne Corp  (NASDAQ: TECH)
 
Price: $72.4300 $-0.02 -0.028%
Day's High: $72.4800033569336 Week Perf: 0.17 %
Day's Low: $ 72.40 30 Day Perf: 0.74 %
Volume (M): 1,855,314 52 Wk High: $ 72.62
Volume (M$): $ 0 52 Wk Avg: $60.44
Open: $72.41 52 Wk Low: $43.20



 Market Capitalization (Millions $) 11,372
 Shares Outstanding (Millions) 157
 Employees 3,000
 Revenues (TTM) (Millions $) 1,214
 Net Income (TTM) (Millions $) 182
 Cash Flow (TTM) (Millions $) 48
 Capital Exp. (TTM) (Millions $) 29

Business Description


Bio-Techne Corporation is a global life sciences company whose mission is to provide innovative, high-quality scientific tools and resources to researchers in diagnostics and therapeutics.
The company was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Bio-Techne operates through four divisions: Protein Platforms, Diagnostics & Genomics, Cell & Gene Therapy, and Clinical Controls.
The Protein Platforms division provides innovative protein analysis tools and technologies to researchers in academic and biopharmaceutical industries.
This includes single-cell proteomics, mass spectrometry, and western blotting among others.
The Diagnostics & Genomics division offers diagnostic kits and reagents for clinical and research markets, including ELISAs, cell culture products, and RNA analysis tools.
The Cell & Gene Therapy division provides innovative solutions for the development and production of cell and gene therapies.
This includes T cell activation reagents, gene editing tools, and viral vector systems among others.
The Clinical Controls division specializes in the production of quality controls and calibrators for clinical laboratories.
These products are used for monitoring the accuracy and precision of laboratory testing procedures.
Bio-Techne operates globally and serves a diverse customer base including biopharmaceutical companies, academic and government institutions, clinical research organizations, and diagnostic laboratories.
The company's dedication to research and development, customer support, and quality control has earned it a reputation of excellence in the life sciences industry.
Bio-Techne has over 3,000 employees worldwide and is committed to advancing science by providing innovative solutions and technologies for researchers and clinicians alike.


   Company Address: 614 McKinley Place N.E. Minneapolis 55413 MN
   Company Phone Number: 379-8854   Stock Exchange / Ticker: NASDAQ TECH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
RGEN   -4.92%    
A   -1.94%    
BIO   -0.41%    
ILMN        1.22% 
MRK        1.33% 
TMO   -1.35%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 62.98
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 9.37
Price to Sales (Expected) -
Price to Book 5.39
PEG (TTM) 0.42

Financial Strength Current
Quick Ratio 1.62
Working Capital Ratio 4.14
Leverage Ratio (MRQ) 0.23
Total Debt to Equity 0.09
Interest Coverage (TTM) -
Debt Coverage (TTM) 1.81

Per Share Current
Earnings (TTM) 1.15 $
Revenues (TTM) 7.73 $
Cash Flow (TTM) 0.3 $
Cash 1.69 $
Book Value 13.43 $
Dividend (TTM) 0.32 $

Efficiency Current
Revenue per Employee (TTM) 404,623
Net Income per Employee (TTM) 60,621
Receivable Turnover Ratio (TTM) 5.91
Inventory Turnover Ratio (TTM) 2.1
Asset Turnover Ratio (TTM) 0.47

Profitability Ratios Current
Gross Margin (MRQ) 65.82 %
Operating Margin (MRQ) 23.13 %
Net Margin (MRQ) 17.01 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 24.44 %

Management Effectiveness Current
Return On Assets (TTM) 7.05 %
Return On Investment (TTM) 7.87 %
Return On Equity (TTM) 9.01 %
Dividend Yield 0.44 %
Pay out Ratio (TTM) 27.83 %



Bio Techne's Segments
Consumables    306.71 % of total Revenue
Instruments    34.44 % of total Revenue
Service    29.36 % of total Revenue
Product and Services    370.51 % of total Revenue
Royalty    7.78 % of total Revenue
US    197.82 % of total Revenue
EMEA Excluding UK    91.6 % of total Revenue
GB    17.52 % of total Revenue
Diagnostics and Spatial Biology    94.73 % of total Revenue
CN    32.4 % of total Revenue
Rest of World    12.23 % of total Revenue
Protein Sciences    211.98 % of total Revenue
Member    377.03 % of total Revenue
Intersegment Elimination    -0.43 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.